Location History:
- Stevenage, GB (2008)
- Harlow, GB (2012)
Company Filing History:
Years Active: 2008-2012
Title: John Skidmore: Innovator in Pharmaceutical Compounds
Introduction
John Skidmore is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on oxadiazole derivatives. With a total of 3 patents to his name, Skidmore's inventions are aimed at addressing various medical disorders.
Latest Patents
Skidmore's latest patents focus on novel oxadiazole derivatives that exhibit pharmacological activity. These compounds are designed for use in pharmaceutical compositions and have potential applications in treating a range of disorders. His work on oxadiazole derivatives active on sphingosine-1-phosphate (S1P) further emphasizes the therapeutic potential of these compounds.
Career Highlights
Throughout his career, John Skidmore has been associated with Glaxo Group Limited, where he has been instrumental in advancing pharmaceutical research. His innovative approach and dedication to developing new compounds have positioned him as a key figure in the industry.
Collaborations
Skidmore has collaborated with several talented individuals, including Thomas Daniel Heightman and Jag Paul Heer. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
John Skidmore's work in the field of pharmaceuticals showcases his commitment to innovation and improving healthcare through his patented inventions. His contributions continue to have a lasting impact on the industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.